The decision to pause its investment in Britain came as AstraZeneca announced plans to spend $3.5bn (£2.7bn) expanding its US ...
Reading ‘Australia’s Pandemic Exceptionalism’ and this official response report is essential for anyone likely to have ...
This column, forecasting a Trump election win, last week expressed surprise so many news consumers remain loyal to media ...
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...
Investor's Business Daily on MSN20h
AstraZeneca Reverses As Beat And Raise Outweighs Drug Smuggling ClaimsAstraZeneca beat third-quarter expectations and lifted its guidance Tuesday, and AstraZeneca stock rose despite a criminal probe in China.
A long negative candle was formed on the daily chart after the upside bounce of the last two sessions. The crucial overhead ...
LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...
COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...
Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1) ...
Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback